Australia Extends Fuel Sulphur Relaxation Amid Iran War Supply Disruptions 
Tesla Q1 Earnings Preview: Robotaxi Delays and SpaceX Merger Speculation Grow 
How Technology Is Reshaping Modern Business: From Operations to Customer Experience 
Nidec Stock Rises After Accounting Probe Report Eases Delisting Concerns 
China Food Delivery Stocks Dip as Regulators Crack Down on “Ghost Deliveries” 
Want to cut your energy bills? Here’s how five experts are doing it 
Daikin Industries Stock Surges 14% After Elliott Investment Management Discloses Major Stake 
TSMC Posts Record Q1 Profit Fueled by AI Chip Demand 
Anthropic CEO Meets Trump Officials to Discuss Powerful New AI Model Mythos 
Netflix Q2 Profit Warning Sends Shares Tumbling as Reed Hastings Exits 
JAPEX Shares Drop as Middle East Tensions Drive LNG Costs and Production Risks 
Apple Wins ITC Ruling, Keeping Blood-Oxygen Feature on Apple Watch 
AEVEX Raises $320 Million in IPO Amid Surging Defense Sector Demand 
OpenAI's $20 Billion Cerebras Deal Signals Massive AI Infrastructure Push 
Chinese Robotics Stocks React as Humanoid Robot Marathon Sparks Competition Concerns 
Elon Musk Faces French Probe Over X and Grok Amid Rising U.S.-EU Tensions 
Indian Refiners Use Yuan via ICICI Bank to Pay for Iranian Oil Under U.S. Sanctions Waiver 
WILMINGTON, Del., March 28, 2016 -- Rigrodsky & Long, P.A.:
- Do you, or did you, own shares of Cardiovascular Systems, Inc. (NASDAQ:CSII)?
- Did you purchase your shares between September 12, 2011 and January 21, 2016, inclusive?
- Did you lose money in your investment?
Rigrodsky & Long, P.A. reminds shareholders of Cardiovascular Systems, Inc. (“CSI” or the “Company”) (NASDAQ:CSII) of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. A complaint was filed in the United States District Court for the Central District of California on behalf of all persons or entities that purchased the common stock of CSI between September 12, 2011 and January 21, 2016, inclusive (the “Class Period”), alleging violations of the Securities Exchange Act of 1934 against the Company and certain of its officers (the “Complaint”).
If you wish to serve as lead plaintiff, you must move the Court no later than April 12, 2016. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Any member of the proposed class may move the court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.
If you purchased shares of CSI during the Class Period, or purchased shares prior to the Class Period and still hold CSI, and wish to discuss this action or have any questions concerning this notice or your rights or interests, please contact Timothy J. MacFall, Esquire or Peter Allocco of Rigrodsky & Long, P.A., 2 Righter Parkway, Suite 120, Wilmington, DE 19803 at (888) 969-4242; by e-mail to [email protected]; or at: http://rigrodskylong.com/investigations/cardiovascular-systems-inc-csii.
Attorney advertising. Prior results do not guarantee a similar outcome.
CONTACT: Rigrodsky & Long, P.A. Timothy J. MacFall, Esquire Peter Allocco (888) 969-4242 (516) 683-3516 Fax: (302) 654-7530 [email protected] http://www.rigrodskylong.com
